TOFACITINIB CITRATE | A219530 | MACLEODS PHARMACEUTICALS LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Pfizer Inc. et al v. Macleods Pharmaceuticals Ltd. 1 patentANDA 219530tofacitinib citrate | D. Del. | 2025-05-21 | Terminated 2025-07-15 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.
Macleods Pharma's tofacitinib citrate product (NDA 219530, Strength 001) was added to the FDA product database.
New: New record
MacLeods Pharmaceuticals Ltd received FDA approval for TOFACITINIB CITRATE (ANDA 219530, Supplement 002).
New: New record